FDA official logo
GSRS logo
PFDA official logo

ALOGLIPTIN BENZOATE

  • UNII: EEN99869SC
  • Formula: C18H21N5O2.C7H6O2
  • Preferred Substance Name: ALOGLIPTIN BENZOATE
  • InChIKey: KEJICOXJTRHYAK-XFULWGLBSA-N

  • 850649-62-6
  • 2-((6-((3R)-3-AMINO-1-PIPERIDINYL)-3,4-DIHYDRO-3-METHYL-2,4-DIOXO-1(2H)- PYRIMIDINYL)METHYL)BENZONITRILE MONOBENZOATE
  • 2-((6-((3R)-3-AMINOPIPERIDIN-1-YL)-3-METHYL-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)METHYL)BENZONITRILE MONOBENZOATE
  • ALOGLIPTIN (AS BENZOATE)
  • ALOGLIPTIN BENZOATE [JAN]
  • ALOGLIPTIN BENZOATE [MART.]
  • ALOGLIPTIN BENZOATE [MI]
  • ALOGLIPTIN BENZOATE [ORANGE BOOK]
  • ALOGLIPTIN BENZOATE [USAN]
  • ALOGLIPTIN BENZOATE [VANDF]
  • ALOGLIPTIN BENZOATE [WHO-DD]
  • ALOGLIPTIN BENZOATE COMPONENT OF KAZANO
  • ALOGLIPTIN BENZOATE COMPONENT OF OSENI
  • BENZONITRILE, 2-((6-((3R)-3-AMINO-1-PIPERIDINYL)-3,4-DIHYDRO-3-METHYL-2,4-DIOXO-1(2H)-PYRIMIDINYL)METHYL)-, MONOBENZOATE
  • KAZANO COMPONENT ALOGLIPTIN BENZOATE
  • NESINA
  • OSENI COMPONENT ALOGLIPTIN BENZOATE
  • SYR 322
  • SYR-322

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.